Skip to main content
. 2022 Sep 15;38(3):235–239. doi: 10.5146/tjpath.2022.01570

Figure 3.

Figure 3

Histology of the patient’s ‘well differentiated endometrial adenocarcinoma’ (Hematoxylin-Eosin, x400).